{
    "code": "02024048",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024048",
    "time": "2020-02-25 13:16:19",
    "許可證字號": "衛署藥輸字第024048號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/08\/12",
    "發證日期": "93\/08\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202404801",
    "中文品名": "大塚安立復錠15毫克",
    "英文品名": "OTSUKA ABILIFY TABLETS 15MG",
    "適應症": "成人和青少年(13至17歲)的思覺失調症。成人和兒童(10至17歲)的雙極性疾患之躁症發作及混合型發作，可單獨使用或做為鋰鹽或Valproate的輔助治療。第一型雙極性疾患維持治療之鋰鹽或valproate的輔助治療。重鬱症之輔助治療。兒童(6至17歲)的自閉性疾患伴隨之急躁易怒。妥瑞氏症。",
    "劑型": "110錠劑",
    "包裝": "2-1000粒鋁箔盒裝 2-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
        "申請商名稱": "1403301100  台灣大塚製藥股份有限公司",
        "申請商地址": "台北市中山區復興北路378號11樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "1403304300  臺灣大塚製藥股份有限公司中壢工廠",
            "製造廠廠址": "中壢市忠福里吉林路１５號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝及分裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095400",
            "成分名稱": "ARIPIPRAZOLE",
            "含量描述": "",
            "含量": "15.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "圓形",
        "特殊劑型": "",
        "顏色": "黃色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "",
        "標記一": "A-009 及 15",
        "標記二": "無"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "A15-尺-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024048&Seq=439&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Abilify Tablets _仿單 (IT0110)-106-02-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024048&Seq=021&Type=9"
        },
        {
            "title": "大塚安立復15mg個裝盒-106-08-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024048&Seq=007&Type=8"
        },
        {
            "title": "A15鋁箔實體-106-08-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024048&Seq=006&Type=8"
        },
        {
            "title": "4_Abilify 15mg_鋁箔-106-01-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024048&Seq=005&Type=8"
        }
    ]
}